MELK increased expression seems to be restricted to cancer tissue [38], [39] while its silencing causes a block of tumour cells proliferation: a result that permits to hypothesize for MELK a role as molecular therapeutic target [39]. The gene discussed is MELK; the disease is neoplasm.